Regeneron Pharma Stock Price (NASDAQ:REGN)

Add to My Stocks
$515.92 $5.21 (1%) REGN stock closing price Jul 21, 2017 (Closing)
Prev Close* : $521.13
Market Cap:
$54.84B
Day Low: $513.4
52 Week Low: $325.35
Open: $518.46
Volume: 617665
Day High: $522
52 Week High: $543.55
Dividend:
N/A

Regeneron Pharma Stock Articles & Video

more news on REGN stock

Regeneron Pharma News - From Partners

Tech Takes the Lead...but for How Long?   by Zacks on Jul 06, 2017

REGN Stockcharts

View REGN PE ratio, PS ratio stocks charts and compare with peers.
REGN Chart
Note: Compare Regeneron Pharma stock price history with the index and industry peers.

Regeneron Pharma Valuation

PE ratio
(price earnings ratio)
62.08
PS ratio (
price to sales ratio
)
10.94
PB ratio (
price to book ratio
)
12.58

Regeneron Pharma Returns

ROE
(return on equity)
22%

Regeneron Pharma Financial Ratios

Asset Turnover
0.71
Receivables Turnover
2.89
Debt to Equity
0.15

REGN Industry Peers

Company Price Change (%)
Gilead Sciences (GILD)73.760.34 (0.46%)
Biogen Inc (BIIB)282.921.48 (0.53%)
Bayer Ag (BAYRY)129.510.96 (0.74%)
Amgen (AMGN)180.210.89 (0.5%)
Novartis (NVS)84.990.43 (0.5%)
Alimera Sciences (ALIM)1.450.13 (8.23%)
Roche Holdings (RHHBY)32.270.07 (0.22%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sarepta Therapeutics (SRPT)43.412.48 (6.06%)
Mirati Therapeutics (MRTX)4.90.25 (5.38%)
Cytokinetics (CYTK)14.50.65 (4.69%)
Fortress Biotech (FBIO)4.870.2 (4.28%)
Revance (RVNC)23.750.95 (4.17%)
BioDelivery Sciences (BDSI)3.250.1 (3.17%)
Compugen (CGEN)3.550.1 (2.9%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 22, 2017
CompanyPriceChange (%)
Peregrine Pharma (PPHM)4.60.62 (11.88%)
Alimera Sciences (ALIM)1.450.13 (8.23%)
Trevena (TRVN)2.7550.22 (7.41%)
Vital Therapies (VTL)2.650.15 (5.36%)
ALBIREO PHARMA (ALBO)26.211.41 (5.1%)
Achillion Pharma (ACHN)4.110.21 (4.86%)
MannKind (MNKD)1.30.06 (4.41%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 22, 2017

Regeneron Pharmaceuticals Inc Stock News - Partner Headlines

Regeneron Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues4.86B4.1B2.82B2.1B1.38B
Net Income895.52M636.05M348.07M424.36M750.26M
Total Operating Expense3.23B2.46B1.78B1.19B836.3M
view Regeneron Pharmaceuticals Inc income statement
balance sheet20162015201420132012
Total Assets6.97B5.61B3.87B2.95B2.08B
Total Liabilities2.52B1.95B1.33B998.93M835.1M
Shareholders Equity4.45B3.65B2.54B1.95B1.25B
view Regeneron Pharmaceuticals Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities228.19M229.82M20.23M-190.66M-672.79M
Net Cash From (Used By) Operating Activities1.47B1.33B743.15M583.64M-74.61M
Increase (Decrease) In Prop Plant And Equipment-511.94M-677.93M-333M-156.32M-49.33M
view Regeneron Pharmaceuticals Inc cashflow statement

Regeneron Pharma Stock Message Board

Regeneron Pharma stock price ended the last trading day at 515.92. Regeneron Pharma market capitalization is 55.39B and it represents the total market value of REGN stock. A value investor must look at the fundamentals of a stock, and perform Regeneron Pharma valuation, even though in the short-term sentiment and current breaking news might affect Regeneron Pharma stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy REGN stock than sell it, then Regeneron Pharma stock price goes up. Conversely, if more investors wanted to sell REGN stock than buy it, there would be greater supply than demand, and the stock price would fall. 617665 REGN shares were traded yesterday, and Regeneron Pharma stock chart shows that the REGN stock quote hit a day high of 522 and day low of 513.4. One can observe stock price trends and check for volatility by checking Regeneron Pharma stock price history.